Real-World Experience of Monitoring Practice of Endocrinopathies Associated with the Use of Novel Targeted Therapies among Patients with Solid Tumors.
Atika M AlHarbiMajed A AlshamraniMansoor Ahmed KhanAbdelmajid AlnatshehMohammed A AseeriPublished in: Medical sciences (Basel, Switzerland) (2022)
Our study showed a high prevalence of monitoring errors among the cancer patients who received targeted therapies which led to endocrinopathies. It emphasizes the importance of adhering to monitoring strategies and following up on the appropriate referral process.